Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.St Jude Medical To Sponsor SCD-HeFT Ten-year Follow-up Study
The original SCD-HeFT study has proved the effectiveness of ICD therapy over placebo or Amiodarone (a medication used to treat irregular heartbeats) for a specific population of patients.
The original SCD-HeFT study has proved the effectiveness of ICD therapy over placebo or Amiodarone (a medication used to treat irregular heartbeats) for a specific population of patients.
In November 2009, the US, several states, and Omnicare entered into a $98m settlement agreement that, among other things, resolved Omnicare’s civil liability under the False Claims Act
China Sky One Medical has completed this first phase of construction in December 2009. The company’s two new six-story buildings cost approximately $13m and will accommodate administration, research
As per the agreement, Altea and KAI are expected to examine the transdermal delivery of certain Kai proprietary compounds using Altea’s transdermal delivery technology, the PassPort System. Moreover,
As per the agreement, CrystalGenomics is expected to receive research funding from AstraZeneca for two years. CrystalGenomics will also be eligible to receive future milestones and royalty payments
Using Kenta’s proprietary hybridoma cell line, Rentschler will develop a manufacturing process for the former’s KBSA301 antibody using, for the first time, single-use bioreactor technology. Nikolaus Rentschler, chief
Robert Pacifici, chief scientific officer of CHDI, said: “As a proven leader in the field of drug discovery, Evotec continues to be an important strategic partner in our
In the comparator study of 903 patients, 68% and 74% of patients receiving subcutaneous injections of Stelara (45mg or 90mg) at weeks zero and four, achieved at least
Robert Wessman, executive chairman of Alvogen, said: “We see great opportunities for our business in Eastern Europe, and the creation of Alvogen Romania is integral to our development
The company said that, with the installation of the new machine, it can produce cold foil blisters or thermoformed blister packages from PVC, PVDC, and barrier films such